粗针活检诊断单纯扁平上皮 atypical 的升级率:系统综述与荟萃分析
该系统综述与荟萃分析纳入42项研究共2482例粗针活检诊断的单纯扁平上皮非典型增生(FEA),计算其 pooled 升级率。单纯FEA升级为乳腺癌的 pooled 率为5%(95%CI 3%,6%),浸润癌1%(95%CI 0%,2%),导管原位癌2%(95%CI 1%,3%);当粗针活检去除超过90%的目标钙化时, pooled 升级率为0%(95%CI 0%,2%)。结论认为单纯FEA应手术切除,若去除超过90%钙化可密切影像随访。
要点
- 粗针活检诊断单纯FEA的 pooled 乳腺癌升级率为5%(95%CI 3%,6%)。
- 当粗针活检去除超过90%目标钙化时, pooled 升级率为0%(95%CI 0%,2%)。
- 手术切除标本中非典型导管增生(ADH)的 pooled 共存率为17%(95%CI 12%,21%)。
关键影像表现/征象
- 单纯FEA粗针活检后手术切除标本中ADH的 pooled 共存率为17%(95%CI 12%,21%)。
诊断标准与关键数值
- 单纯FEA的 pooled 乳腺癌升级率为5%(95%CI 3%,6%)。
- 单纯FEA的 pooled 浸润癌升级率为1%(95%CI 0%,2%)。
- 单纯FEA的 pooled 导管原位癌(DCIS)升级率为2%(95%CI 1%,3%)。
- 粗针活检去除超过90%钙化时,单纯FEA的 pooled 升级率为0%(95%CI 0%,2%)。
临床应用与阅片要点
- 粗针活检诊断为单纯FEA时,因乳腺癌升级率为5%,应建议手术切除。
- 若粗针活检已去除超过90%的目标钙化,可考虑密切影像随访而非立即手术。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To perform a systematic review and meta-analysis to calculate the pooled upgrade rate of pure flat epithelial atypia (FEA) diagnosed at core needle biopsy (CNB).
MATERIALS AND METHODS: A PubMed and Embase database search was performed in December 2019. Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. Study quality and publication bias were assessed. The upgrade rate of pure FEA to cancer, invasive carcinoma, and ductal carcinoma in situ (DCIS), as well as the co-occurrence rate of atypical ductal hyperplasia (ADH), with 95% CIs were calculated. A random effect model was used to integrate the proportions and their corresponding 95% CI. Study heterogeneity was calculated using τ2 and I 2 .
RESULTS: A total of 2482 cases of pure FEA across 42 studies (mean age range, 46-59 years) met inclusion criteria to be analyzed. Significant study heterogeneity was identified (τ2 = 0.001, I 2 = 67%). The pooled upgrade rates reported for pure FEA were 5% (95% CI: 3%, 6%) for breast cancer, 1% (95% CI: 0%, 2%) for invasive carcinoma, and 2% (95% CI: 1%, 3%) for DCIS. When more than 90% of calcifications were removed at CNB, the pooled upgrade rate was 0% (95% CI: 0%, 2%). The pooled co-occurrence rate of ADH at surgical excision was 17% (95% CI: 12%, 21%). Study quality was medium to high with a risk of publication bias (P < .01).
CONCLUSION: Pure FEA diagnosed at CNB should be surgically excised due to the pooled upgrade rate of 5% for breast cancer. If more than 90% of the targeted calcifications are removed by CNB for pure FEA, close imaging follow-up is recommended.Keywords: Biopsy/Needle Aspiration, Breast, MammographySupplemental material is available for this article.© RSNA, 2021.
引用
- Wahab RA, Lee SJ, Mulligan ME, et al. Upgrade Rate of Pure Flat Epithelial Atypia Diagnosed at Core Needle Biopsy: A Systematic Review and Meta-Analysis. Radiol Imaging Cancer. 2021. PMID: 33778758. doi:10.1148/rycan.2021200116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。